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Abstract: 
The metabolite profiling of different parts of Panax notoginseng was carried out using rapid 
ultra-performance liquid chromatography–electrospray ionization mass spectrometry (UPLC–
ESI-MS) and multivariate statistical analysis. Principal component analysis (PCA) of the UPLC–
ESI-MS data showed a clear separation of compositions among the flower buds, roots and 
rhizomes of P. notoginseng. The saponins accounting for such variations were identified through 
the corresponding loadings weights and were further verified by accurate mass, tandem mass and 
retention times of available standard saponins using UPLC quadrupole time-of-flight mass 
spectrometer (UPLC–QtofMS). Finally, the influential factors of different metabolic phenotypes 
of P. notoginseng was elucidated. The currently proposed UPLC–ESI-MS/MS analytical method 
coupled with multivariate statistical analysis can be further utilized to evaluate chemical 
components obtained from different parts of the plant and/or the plant of different geographical 
locations, thereby classifying the medicinal plant resources and potentially elucidating the 
mechanism of inherent phytochemical diversity. 
 
Article: 
INTRODUCTION 
According to the World Health Organization (WHO), about 65–80% of the world’s population is 
using herbal medicine as the primary form of healthcare (Akerele, 1992). Panax notoginseng 
(Burk.) F.H. Chen (Araliaceae) (Sanqi or Tianqi in Chinese) is a highly valuable and important 
tonic herb cultivated mainly in Yunnan province, PR China. Extensive phytochemical and 
pharmacological studies on P. notoginseng (Wang et al., 2006a and Wang et al., 2006b) have 
isolated and characterized a total of 56 dammarane-type saponins, most of which have proved to 
be bioactive for prevention and treatment of cardiovascular and cerebrovascular diseases (Cicero 
et al., 2003 and Ma et al., 1998), immunoregulation (Sun et al., 2006), hepatoprotection (Ng, 
2006), and anti-carcinogenesis (Konoshima et al., 1999). Specifically, ginsenoside Rb3, one of 
20(S)-protopanaxadiol type saponins (Taniyasu et al., 1982 and Xiao, 2002), with a high 
concentration in the flower buds, exhibited a strong neuroprotective effect (Xu et al., 2005), 
whereas ginsenoside Rb1 present mainly in the root has been reported to protect against free 
radical damage, maintain normal cholesterol levels and blood pressure, and inhibit the induction 
phase of long-term potentiation induced by high-frequency stimulation in the dentate gyrus of 
anesthetized rats in a dose-dependent manner (Wang and Zhang, 2003). These saponins in the 
different parts of P. notoginseng including roots, rhizomes and flower buds, ‘either alone or in 
combination’, account for diverse therapeutic effects. Thus understanding the bio-distribution of 
these secondary metabolites in different parts of P. notoginseng is paramount for the 
investigation of their pharmacological efficiency (Wang et al., 2005). 
 
Metabolites are the end products of cellular regulatory processes, and their fluxes and levels can 
be regarded as the ultimate response of biological systems to control genetic or environmental 
changes (Fiehn, 2002). Selectively monitoring important metabolites derived from a biological 
system allows phytochemists to depict the inherent similarities and differences among the 
various plants and the various parts of the same plant (Wang et al., 2004b). In parallel with the 
flourish of ‘transcriptome’ and ‘proteome’ in the functional genomic era, metabolomics or 
metabolite profiling, aiming to identifying and quantifying the entire spectrum of the metabolites 
in biological systems, has aroused extensive awareness and interests (Rochfort, 2005), especially 
in the botanical studies such as quality control of plants (Chang et al., 2006, Huhman and 
Sumner, 2002 and IIka et al., 2007), plant engineering (Anterola and Lewis, 2002 and Long et 
al., 2006), and clinical trials (Dong and He, 2006). To date, high performance liquid 
chromatography–mass spectrometry (HPLC–MS) (Murch et al., 2004) and gas chromatography–
mass spectrometry (GC–MS) (Farag et al., 2007 and Fukusaki et al., 2006) have been widely 
employed for high-throughput metabolite profiling strategy. Recently, the soaring development 
of column particle materials has highlighted a new addition to chromatographic separation 
technology, the ultra-performance liquid chromatography (UPLC), which allows satisfactory 
separation, good resolution and sensitivity, and high-speed detection (Wilson et al., 2005) with 
complex biological samples, such as herbal medicine (Guan et al., 2007). The UPLC coupled 
with MS has become a more powerful tool to simultaneously identify and quantify the 
complicated components in herbal medicine (Chan et al., 2007). 
 
In this paper, we describe a high-throughput and reliable UPLC–ESI-MS-based analytical 
method in association with principal component analysis (PCA) to profile and discriminate the 
samples from different parts of P. notoginseng. Accurate mass and tandem mass were used to 
identify these significantly altered compositions with bioactivity present in different parts of P. 
notoginseng using UPLC–QtofMS. Further, we identified the tentative mechanism of metabolic 
outcomes diversity. 
 
RESULTS AND DISCUSSION 
Saponins profiling of different parts of P. notoginseng 
As compared with simultaneous determination of several saponins in P. notoginseng, (Li et al., 
2005a, Liu et al., 2004, Wang et al., 2006a and Wang et al., 2006b), the metabolite profiling 
study requires higher resolution and sensitivity. UPLC–ESI-MS system was employed to provide 
a rapid, effective, and convenient profiling analytical method for a wide range of saponins 
present in P. notoginseng. Theoretically, a higher flow rate (above 0.6 ml/min) promises a good 
separation using UPLC, whereas the flow rate for the electrospray source is below 1.0 ml/min. 
Meanwhile, flow into the ion source should be limited within 0.2 ml/min, so as to guarantee the 
ionization efficiency and ameliorate ion suppression which significantly reduces analytical 
sensitivity. Considering sensitivity and resolution together, the ultimate flow rate was optimized 
at 0.35 ml/min throughout the study. In addition, the effects of formic acid at different 
concentrations (0.1%, 0.05% and 0.01%) were tested, and 0.01% formic acid exhibited good 
separation with slight reduction of peak signal. The column temperature was set at 40 °C to 
alleviate extra column pressure resulting from a higher flow rate, which can improve 
chromatographic separation and peak shape. Isocratic elution commonly led to the overlapped 
peaks mainly due to similar polarity and structure of most ginsenosides; hence gradient elution 
was adopted to obtain better separation and lower LOQ. Compared with pervious HPLC research 
suffering long run time as long as 50 min (Li et al., 2005b), the major saponins were excellently 
separated as well as superior peak shape, especially fourteen saponins quantified during 21 min. 
 
More information on saponins was obtained in the ES+ mode than ES− mode due to higher 
degree of ion fragmentation as revealed by the representative total ion current (TIC) spectra on 
the UPLC–ESI-MS. Despite of the coexistence of three major fragment ions [M+Na]+, [M+K]+, 
and [M+H]+, we adopted the adduct ion of [M+Na]+ as the target m/z in terms of the abundance 
and constant of [M+Na]+, which was reported in P. ginseng (Cui et al., 2001 and Liu et al., 
2006). The desolvation gas flow was set at 600 l/h, cone gas flow at 50 l/h, and desolvation 
temperature at 300 °C, respectively, so as to remove redundant solvent resulting from a higher 
flow rate of 0.35 ml/min for single quadrupole mass spectrometer. Cone voltage was optimized 
to the corresponding values ranging from 25 V to 90 V owing to the broad range of molecular 
weight of saponins (400–1400 Da). The simultaneous separation and detection of the metabolites 
using UPLC–ESI-MS required an analytical method with high precision, repeatability, and 
recovery. In general, the proposed method exhibits reliable accuracy, and good reproducibility 
(Stable 1). 
 
Visual inspection of UPLC–ESI-MS spectra 
Most of the 14 reference standards (Fig. 1) were readily identified within the UPLC–ESI-MS 
spectra of roots, rhizomes and flower buds of P. notoginseng via paired retention time and mass 
to charge ratio (paired Rt−m/z). Visual inspection of the spectra from the different parts of P. 
notoginseng revealed a salient difference with each other. The ginsenoside Rb3 concentration 
was relatively higher in the flower bud than in the root while the content of ginsenoside Rg1 was 
higher in the root and rhizome than in the flower bud and ginsenoside F1 can barely be detected 
in the flower bud, etc. These findings indicated that there existed different kinds of saponins with 
diverse concentrations in the different parts of P. notoginseng. However, for further 
interpretation of the variations among samples from different parts of the plant, multivariate 
statistical analysis such as PCA was employed in this study. 
 
Figure 1: Saponins 1–25 observed by positive-ion UPLC–ESI-MS in P. notoginseng (Glc, β-d-glucose; Rha, α-l-
rhamnose; Ara(p), α-l-arabinose (pyranose); Ara(f), α-l-arabinose (furanose); Xyl, β-d-xylose). 
Principal component analysis 
PCA is an unsupervised clustering method requiring little prior knowledge of the data set and 
acts to reduce the dimensionality of multivariate data without losing important information 
(Eriksson et al., 2001). Both UV-scaled (scaled to standard deviation) and Par-scaled (scaled to 
square root of standard deviation) mathematical methods were performed to pre-treat the data 
sets resulting from roots, rhizomes and flower buds of P. notoginseng. The clear separation of 
the three different parts was observed in the PCA scores plot where each coordinate represents a 
sample (Fig. 2). Two-component PCA model cumulatively accounted for 80.0% of variation. 
The flower buds and the others were clearly separated by the principal component 1 (PC1), 
whereas the roots and rhizomes were readily discriminated by the principal component 2 (PC2). 
However, the UV-scaled loadings were difficult to be interpreted, because their relative values 
are strongly distorted by the variance scaling procedure (Cloarec et al., 2005). In this work, 
therefore, PCA scores plot and loadings plot were achieved using mean-centered, Par-scaled 
data. The preferential distribution of marker ions in the first quadrant of the loadings plot 
accounted primarily for the difference of roots. Analogously, the distribution in the second and 
third quadrants of the loadings plot indicated the variation of rhizomes and flower buds of P. 
notoginseng, respectively. 
 
 
 
Figure 2: PCA scores plot (PC1 vs. PC2) of 70% methanol extracts of three parts of P. notoginseng: seven flower 
bud samples, eight root samples and six rhizome samples. 
 
 
Tentative marker assignment 
It is possible to determine variable importance by analyzing the correlation between variables in 
the PC1 and PC2 dimension, a list of marker ions of interest was therefore obtained from the 
PCA loadings plot (Fig. 3). Marker ions m/z 823.8([M+Na]+, Rt 3.59 min), 984.9([M+Na]+, Rt 
2.92 min), 1131.8([M+Na]+, Rt 9.31 min), 1145.7([M+Na]+, Rt 7.06 min), and 1147.8([M+Na]+, 
Rt 6.76 min) mainly present in the first quadrant are to characterize the roots of P. notoginseng. 
Marker ions 1102.1([M+Na]+, Rt 10.73 min), 1101.9([M+Na]+, Rt 11.85 min), 1365.9([M+Na]+, 
Rt 9.85 min), 1365.8([M+Na]+, Rt 10.03 min), 1233.8 ([M+Na]+, Rt 11.09 min) and 
807.9([M+Na]+, Rt 17.87 min) are far from the centre in the third quadrant of the loadings plot, 
suggesting that these components exhibit a higher importance in the flower buds than that in the 
other two parts of P. notoginseng. Marker ions 645.8([M+Na]+, Rt 20.17 min), 807.9([M+Na]+, 
Rt 8.42 min), 823.8([M+Na]+, Rt 7.99 min), 956.4([M+Na]+, Rt 3.35 min), 969.7([M+Na]+, Rt 
12.97 min), 979.8([M+Na]+, Rt 3.62 min), 972.1([M+Na]+, Rt 3.40 min), 1102.1([M+Na]+, Rt 
12.26 min), 1218.2([M+Na]+, Rt 5.60 min), 1264.3([M+Na]+, Rt 7.55 min) and 1264.5 
([M+Na]+, Rt 8.12 min) are predominant compounds in the rhizomes. 
 
 
 
Figure 3: PCA loadings plot of all the UPLC–ESI-MS signals of different parts of P. notoginseng. 
 
 
In order to identify these important marker ions, qualitative analysis of saponins present in the 
flower buds, roots and rhizomes of P. notoginseng was carried out on an UPLC coupled to ESI 
quadrupole time-of-flight mass spectrometry (UPLC–ESI–QtofMS) in positive mode. Accurate 
mass measurement was rendered possible by the simultaneous, but independent acquisition of 
reference ions of leucine-enkephalin via the LockSpray™ interface. This configuration offered 
several advantages for untargeted metabolite profiling including minimization of ion suppression 
due to reference ions, prevention of fluctuations in reference ionization efficiency due to gradient 
elution. Using this approach, improved mass accuracy data were acquired in the range of 0.2–
14 ppm, which significantly reduces the number of possible structures of saponins. However, 
mass accuracy data does not provide sufficient information necessary to distinguish saponins 
with the same molecular weight, tandem MS and available standards were used to verify these 
important marker ions. MS/MS analysis of saponins in this study was performed at different 
collision energies ranging from 6 V to 10 V in order to obtain the more sensitive response for 
each product ion. A total of 14 saponins (notoginsenoside R116, R219, ginsenoside Rb14, Rb27, 
Rb39, Rc 10, Rd 11, F212, 20(R)–Rg313, Rh214, Rg117, Re 18, Rg221, and F122) (Table 1) 
were verified by comparing the accurate mass and retention time with those of standards 
available, and the contents of these saponins were quantified using corresponding calibration 
curve of the spiked 14 standards. The remaining 11 marker ions were provisionaly identified as 
notoginsenoside R42, Fa 3, Q 5, S 6, Fc 8, H 23, A 24, B 25, ginsenoside Rf20, malonyl-
ginsenoside-Rb11 and 20-O-glucoginsenoside-Rf15 using accurate mass and tandem mass 
spectrometry, further studies should be initiated for identification and quantification of those 
saponins when the reference standards are available. The improved mass accuracy data and 
tandem mass data are provided in Table 2. Using such a strategy, ginsenoside Rb14, Rg117, 
notoginsenoside A 24, B 25 and 20-O-glucoginsenoside-Rf15 are considered as the critical 
marker ions (compounds) in the roots, which are the main active saponins in the roots of P. 
notoginseng. Notoginsenoside Q 5, S 6, Fc 8, ginsenoside Rb27, Rb39, and F212, tentatively 
assigned as marker ions, mainly existed in the flower buds of P. notoginseng, which were 
reported by previous studies (Wan et al., 2006 and Yoshikawa et al., 2003). Ginsenoside Re 18, 
Rf20, Rg221, notoginsenoside R116, (protopanaxatriol-type saponins), notoginsenoside R42, Fa 
3, ginsenoside Rc 10, Rd 11, Rh214, Malonyl-ginsenoside-Rb11 (protopanaxadiol-type saponins) 
and notoginsenoside H 23 identified in this study are representative ions for rhizome of P. 
notoginseng, which is consistent with the report that the amount of protopanaxatriol-type 
saponins is higher in the rhizome of P. notoginseng than in the root whereas the contents of 
many protopanaxadiol-type saponins are higher in both the rhizome and flower bud of P. 
notoginseng than in the root (Wei and Du, 1996). 
 
 
Table 1: The average contents (mg/g) of investigated 14 saponins in different parts of P. 
notoginseng 
 Rhizome (n = 6) Root (n = 8) Flower bud (n = 7) 
Notoginsenoside R1(16) 3.64 ± 0.34 2.76 ± 0.26 1.30 ± 0.09 
Notoginsenoside R2(19) 2.79 ± 0.36 1.48 ± 0.70 1.63 ± 0.54 
    
Ginsenoside Rb1(4) 42.53 ± 9.34 37.67 ± 8.13 53.13 ± 4.67 
Ginsenoside Rb2(7) 0.27 ± 0.02 ND 21.08 ± 2.70 
Ginsenoside Rb3(9) 5.82 ± 0.53 0.79 ± 0.13 55.63 ± 9.39 
Ginsenoside Rc (10) 9.96 ± 0.81 0.84 ± 0.32 32.02 ± 11.66 
Ginsenoside Rd (11) 7.77 ± 0.55 3.11 ± 0.37 2.54 ± 0.70 
Ginsenoside F2(12) 0.67 ± 0.18 0.40 ± 0.07 3.06 ± 0.21 
Ginsenoside 20(R)–Rg3(13) 1.03 ± 0.07 0.99 ± 0.07 6.90 ± 0.36 
Ginsenoside Rh2(14) 0.14 ± 0.01 ND ND 
Ginsenoside Rg1(17) 42.10 ± 3.13 44.72 ± 6.30 4.44 ± 0.44 
Ginsenoside Re (18) 9.27 ± 0.76 6.22 ± 1.41 1.06 ± 0.05 
Ginsenoside Rg2(21) 1.79 ± 0.42 1.19 ± 0.41 2.28 ± 0.68 
Ginsenoside F1(22) 0.14 ± 0.01 ND ND 
 
  
Table 2: Precursor and product ions of the Saponins 1–25 in the different parts of P. notoginseng using UPLC–QtofMS 
[m/z with relative abundance (%) in parentheses] 
Compound 
number 
Identification Rt 
(min) 
Theoretical 
accurate mass 
QtofMS 
(m/z)(ESI+) 
Mass accuracy 
(ppm) 
MS/MS fragment ion (m/z) 
1 Malonyl-ginsenoside-
Rb1 
5.60 1195.6112[M+H]+ 1195.6099[M+H]+ 1.09 1108.6008(88)[M+H−Mal]+, 
946.5451(14)[M+H−Mal−Glc]+, 
853.4939(100)[M+H−GlcGlc−H2O]+, 
835.4861(38)[M+H−GlcGlc−2H2O]+, 
785.0267(5)[M+H−GlcGlc−Mal]+ 
2 Notoginsenoside-R4 7.55 1241.6530[M+H]+ 1241.6539[M+H]+ 0.72 1109.63104(75)[M+H−Xyl]+, 
1079.6015(100)[M+H−Glc]+, 
947.5589(43)[M+H−Xyl−Glc]+, 
785.5032(70)[M+H−Xyl−GlcGlc]+ 
3 Notoginsenoside-Fa 8.12 1241.6530[M+H]+ 1241.6538[M+H]+ 0.64 1109.6135(100)[M+H−Xyl]+, 
1079.6025(37)[M+H−Glc]+, 
947.5553(15)[M+H−Xyl−Glc]+, 
785.5049(63)[M+H−GlcXyl−Glc]+, 
460.6224(23)[M+H−GlcGlcXyl−GlcGlc]+ 
4 Ginsenoside-Rb1 9.31 1109.6108[M+H]+ 1109.6175[M+H]+ 6.04 947.5649(100)[M+H−Glc]+, 
785.5129(65)[M+H−GlcGlc]+, 
767.5134623(79)[M+H−GlcGlc−H2O]+, 
4621(38)[M+H−GlcGlcGlc]+ 
5 Notoginsenoside-Q 9.85 1343.6847[M+H]+ 1343.6850[M+H]+ 0.22 1211.6432(100)[M+H−Xyl]+, 
1079.6038(52)[M+H−XylXyl]+, 
947.5563(15)[M+H−XylXyl−Xyl]+, 
917.5463(56)[M+H−GlcXyl−Xyl]+ 
6 Notoginsenoside-S 10.03 1343.6847[M+H]+ 1343.6841[M+H]+ 0.45 1211.6414(35)[M+H−Xyl]+, 
1079.6009(100)[M+H−AraXyl]+, 
947.5542(26)[M+H−AraXyl−Xyl]+, 
785.5043(49)[M+H−GlcXyl−AraXyl]+ 
7 Ginsenoside-Rb2 10.73 1079.6002[M+H]+ 1079.5970[M+H]+ 2.96 947.5519(100)[M+H−Ara]+, 
917.5454(44)[M+H−Glc]+, 
785.5001(52)[M+H−Ara−Glc]+, 
767.4929(21)[M+H−Ara−Glc−H2O]+, 
624.0578(17)[M+H−Ara−GlcGlc]+ 
8 Notoginsenoside Fc 11.09 1211.6425[M+H]+ 1211.6450[M+H]+ 2.06 1079.6053(64)[M+H−Xyl]+, 
1049.5936(100)[M+H−Glc]+, 
917.5442(34)[M+H−Xyl−Glc]+, 
785.5079(82)[M+H−Xyl−GlcXyl]+, 
623.4542(32)[M+H−GlcXyl−GlcXyl]+ 
9 Ginsenoside-Rb3 11.85 1079.6002[M+H]+ 1079.6011[M+H]+ 0.83 1043.6021(27)[M+H−H2O]+, 
947.5543(32)[M+H−Xyl]+, 
917.5489(68)[M+H−Glc]+, 
785.5028(100)[M+H−Glc−Xyl]+, 
623.4528(35)[M+H−Glc−GlcXyl]+ 
10 Ginsenoside-Rc 12.26 1079.6002[M+H]+ 1079.6027[M+H]+ 2.32 947.5633(38)[M+H−Ara]+, 
911.5621(82)[M+H−Ara−2H2O]+, 
785.5124(17)[M+H−Ara−Glc]+, 
767.4987(100)[M+H−Ara−Glc−H2O]+, 
623.4592(15)[M+H−Ara−GlcGlc]+ 
11 Ginsenoside-Rd 12.97 947.5579[M+H]+ 947.5557[M+H]+ 2.32 929.5521(43)[M+H−H2O]+, 
785.5032(100)[M+H−Glc]+, 
767.5037(9)[M+H−Glc−H2O]+, 
623.4514(76)[M+H−Glc−Glc]+, 
461.3921(57)[M+H−GlcGlc−Glc]+ 
12 Ginsenoside-F2 17.87 785.5051[M+H]+ 785.4985[M+H]+ 8.40 623.4450(67)[M+H−Glc]+, 
605.4434(100)[M+H−Glc−H2O]+, 
587.4310(82)[M+H−Glc−2H2O]+, 
461.7453(29)[M+H−Glc−Glc]+ 
13 20(R)-Ginsenoside-
Rg3 
18.47 785.5051[M+H]+ 785.4946[M+H]+ 13.37 623.4408(100)[M+H−Glc]+, 
461.3887(39)[M+H−GlcGlc]+, 
425.3821(48)[M+H−GlcGlc−2H2O]+ 
14 
 
 
 
 
 
Ginsenoside-Rh2 20.17 623.4523[M+H]+ 623.4507[M+H]+ 2.57 540.2374(84)[M−C6H11]+, 
461.3986(77)[M+H−Glc]+, 
443.3967(100)[M+H−Glc−H2O]+ 
15 20-O-
glucoginsenoside-Rf 
2.92 963.5529[M+H]+ 963.5542[M+H]+ 1.35 801.5035(78)[M+H−Glc]+, 
621.4284(100)[M+H−GlcGlc−H2O]+, 
603.4288(36)[M+H−GlcGlc−2H2O]+, 
477.3954(23)[M+H−GlcGlc−Glc]+, 
441.4041(17)[M+H−GlcGlc−Glc−2H2O]+ 
16 Notoginsenoside-R1 3.35 933.5423[M+H]+ 933.5434[M+H]+ 1.18 801.5051(60)[M+H−Xyl]+, 
771.4913(100)[M+H−Glc]+, 
639.4431(49)[M+H−Xyl−Glc]+, 
621.4483(60)[M+H−Xyl−Glc−H2O]+, 
477.7496(37)[M+H−XylGlc−Glc]+ 
17 Ginsenoside-Rg1 3.59 801.5001[M+H]+ 801.4904[M+H]+ 12.10 639.8921(65)[M+H−Glc]+, 
621.8903(100)[M+H−Glc−H2O]+, 
477.7514(38)[M+H−GlcGlc]+ 
18 Ginsenoside-Re 3.62 947.5579[M+H]+ 947.5575[M+H]+ 0.42 801.4967(100)[M+H−Rha]+, 
785.5054(77)[M+H−Glc]+, 
639.4451(35)[M+H−Rha−Glc]+, 
603.4451(72)[M+H−Rha−Glc−2H2O]+, 
477.1841(30)[M+H−Rha−GlcGlc]+ 
19 Notoginsenoside-R2 7.21 771.4895[M+H]+ 771.4862[M+H]+ 4.28 639.4401(54)[M+H−Xyl]+, 
609.4347(100)[M+H−Glc]+, 
477.3912(22)[M+H−Xyl−Glc]+, 
457.7413(8)[M+H−GlcGlc−GlcGlc−H2O]+ 
20 Ginsenoside-Rf 7.99 801.5000[M+H]+ 801.5012[M+H]+ 1.50 639.4473(84)[M+H−Glc]+, 
621.4410(100)[M+H−Glc−H2O]+, 
477.3988(5)[M+H−GlcGlc]+ 
21 Ginsenoside-Rg2 8.42 785.5051[M+H]+ 785.5024[M+H]+ 3.44 639.4417(49)[M+H−Rha]+, 
621.4434(100)[M+H−Rha−H2O]+, 
477.3929(51)[M+H−Rha−Glc]+ 
22 Ginsenoside-F1 11.20 639.4472[M+H]+ 639.4412[M+H]+ 9.38 477.3887(100)[M+H−Glc]+, 
441.3843(79)[M+H−Glc−2H2O]+ 
23 Notoginsenoside-H 3.40 949.5372[M+H]+ 949.5350[M+H]+ 2.32 817.4925(76)[M+H−Xyl]+, 
655.4386(100)[M+H−Xyl−Glc]+, 
619.4322(38)[M+H-Xyl−Glc−2H2O]+, 
493.3864(55)[M+H−GlcXyl−Glc]+ 
24 Notoginsenoside-A 6.76 1125.6057[M+H]+ 1125.6032[M+H]+ 2.22 963.5538(78)[M+H−Glc]+, 
801.4965(58)[M+H−GlcGlc]+, 
783.4942(100)[M+H−GlcGlc−H2O]+, 
477.3932(25)[M+H−GlcGlc−GlcGlc]+ 
25 Notoginsenoside-B 7.06 1123.5900[M+H]+ 1123.5923[M+H]+ 2.05 961.5591(83)[M+H−Glc]+, 
799.4989(41)[M+H−GlcGlc]+, 
763.4942(100)[M+H−GlcGlc−2H2O]+, 
457.7323(18)[M+H−GlcGlc−GlcGlc−H2O]+ 
 
 
In parallel, all these marker ions obtained from loadings plot of PCA should be validated at a 
univariate level. Since each peak detected has been normalized to alleviate the effects of possible 
discrepancy and systematic bias ( [Wang et al., 2004a] and [Webb-Robertson et al., 2005]), the 
PCA loadings are in good agreement with the variation of relative concentration, instead of 
variation of absolute content for a particular composition. A total of nine compounds with higher 
loadings identified were listed in the Supplementary data (Table S2) for better understanding of 
the separation among groups in PCA scores plot. For example, the absolute content of Rb14 was 
slightly higher in the flower buds than in rhizomes/roots, although loading in PC1 was in good 
accordance with relative content of Rb14. Analogously, the relative concentration of Rd 11 was 
larger in rhizomes/roots than in flower buds, which is consistent with the loading in PC1. 
 
Potential mechanism for different metabolic phenotype 
During the general process of ginsenoside biosynthesis, the triterpene aglycone of ginsenoside, 
proopanaxadiol, is able to be synthesized from 2,3-oxidosqualene that is synthesized via the 
mevalonate pathway in the cytosol. Protopanaxadiol is subsequently converted to 
protopanaxatriol by a member of the cytochrome P450 family. Different ginsenosides are 
ultimately synthesized by adding one or several monosaccharides to these triterpene aglycones 
via glycosyltransferase (Haralampidis et al., 2002 and Suzuki et al., 2002). Thus, activity and/or 
the amount of cytochrome P450 may lead to the varied contents of protopanaxadiol and 
protopanaxatriol type saponin among the root, rhizome and flower bud of P. notoginseng. 
Additionally, the second key enzyme during the ginsenoside biosynthesis process is saponin 
glycosyltransferase with the ability to catalyze the adduction of monosaccharides to sapogenins, 
the saponin aglycone substrate (Choi et al., 2005), suggesting that the saponins with diversity of 
glycosyl probably attribute to the different saponin glycosyltransferase in the different parts of P. 
notogensing. However, further investigations are necessary for clearly elucidating whether 
certain genes and enzymes are involved in the ultimate metabolite phenotype. 
 
CONCLUSIONS 
UPLC–ESI-MS was used for metabolite profiling of saponins in P. notoginseng, which is 
applicable for analysis and evaluation of complex herbal medicines. Furthermore, the proposed 
analytical method coupled with multivariate statistical analysis technique is used as a powerful 
tool to differentiate phytochemical compositions among different parts of P. notoginseng. In 
addition, UPLC–QtofMS performed systematic identification of tentative markers of P. 
notoginseng using accurate mass and tandem MS. The chemical compounds accountable for the 
different metabolite profiles of the three parts are notoginsenoside R42, Fa 3, Q 5, S 6, Fc 8, 
R116, H 23, A24, B 25, ginsenoside Rb14, Rb27, Rb39, Rc 10, Rd 11, F212, Rh214, Rg117, Re 
18, Rf20, Rg221, malonyl-ginsenoside-Rb11 and 20-O-glucoginsenoside-Rf15, all of which are 
significantly up- or down- regulated in different parts of the plant. Thus, such a UPLC–ESI-MS-
based metabolite profiling strategy is promising for revealing and elucidating the metabolic 
outcomes as a result of genetic diversity, seasonal and geographical variations, and different 
cultivation methods employed. Hence, this work is of great importance for the evaluation of 
overall quality of medicinal plants, ultimately of great significance in the pharmacological and 
clinical investigation of drug products of plant origin. 
 
EXPERIMENTAL 
Plant materials 
A total of seven flower buds, eight roots and six rhizomes of P. notoginseng were collected from 
Wenshan Prefecture, Yunnan Province, PR China. The different parts of P. notoginseng were 
identified by Mengyue Wang, Ph.D. of Pharmacognoy, Shanghai Jiao Tong University, PR 
China. 
 
Reagents and standards 
Notoginsenoside R116, ginsenoside Rb14, Rg117 and Re 18 standards were purchased from the 
National Institute for the Pharmaceutical and Biological Products (Beijing, PR China), whereas 
ginsenoside Rb27, Rb39, Rc 10, Rd 11 and F212 standards were obtained from Sanqi Research 
Institute of Wenshan Prefecture (Wenshan, Yunnan Province, PR China). Notoginsenoside R218, 
ginsenoside Rh214, 20(R)–Rg313, Rg221, and F122 were procured from Wuhu DELTA Co. 
(Wuhu, Anhui Province, RP China). HPLC-grade CH3CN was purchased from Merck Company 
(Darmstadt, Germany), whereas leucine-enkephalin and HCO2H were obtained from Sigma–
Aldrich (St. Louis, MO, USA). Ultra-pure H2O was prepared with the Sartorius Arium611UF 
water purification system (Sartorius, Göttingen, Germany). 
 
Sample preparation 
A total of 20 mg of different parts of P. notoginseng were individualy added into centrifuge tube 
(2 ml) containing MeOH-H2O (1 ml, 7:3, v/v), briefly shaken for 30 s, and ultrasonicated for 1 h 
at 50 °C for three times. The combined MeOH extracts, after removing the solvent in vacuo, 
were dissolved in MeOH-H2O (1 ml, 7;3, v/v), of which 100 μl was diluted to 1 ml and filtered 
through a 0.22 μm filter (Millipore, MA, USA) prior to injection into the UPLC system. 
 
Liquid chromatography 
The UPLC–ESI-MS system was performed on an ACQUITY UPLC™ system (Waters Co., MA, 
USA), equipped with a binary solvent delivery system and an autosampler. Chromatographic 
separation was carried out on an ACQUITY UPLC™ BEH C18 column (50 mm × 2.1 mm, 
1.7 μm particle size) (Waters Co., MA, USA). The column was maintained at 40 °C. The mobile 
phase consisted of 0.01% HCO2H in H2O as solvent A and CH3CN as solvent B. Separation was 
performed by gradient elution: 0 min 90% A, 3 min 75% A, 10 min 70% A, 16 min 65% A, 
18 min 50% A and 21 min 35% A with the flow rate of 0.35 ml/min. The injection volume of the 
test sample was 5 μl. Each wash cycle consisted of 200 μl of strong wash solvent (90% CH3CN-
H2O, 9:1, v/v) and 600 μl of weak wash solvent (10% CH3CN-H2O, 1:9, v/v). 
 
Mass spectrometry 
Mass spectrometry was carried out on a Micromass-ZQ mass spectrometer (Waters Co., MA, 
USA). ESI mass spectra were acquired in positive ion electrospray ionization mode by scanning 
over the m/z range 400–1400. The ESI capillary voltage was set at 3.0 kV. The temperatures of 
electrospray source and desolvation gas were 100 °C and 300 °C, respectively. N2 was used as 
the nebulizing gas, desolvation gas and cone gas at the flow-rates of 60, 600 and 50 l/h, 
respectively. The cone voltage varied over the range 25–90 V to investigate the intensities and 
distribution of ions in the mass spectra of ginsenosides. 
 
Accurate mass measurement and MS/MS spectrometry were performed to identify ion markers 
using a Q-tof Premier™ mass spectrometer (Waters Co., MA, USA). Leucine-enkephalin was 
used as independent reference lock-mass ions via the LockSpray™ to ensure mass accuracy and 
reproducibility. For ES+, [M+H]+ ion of leucine-enkephalin at 556.2771 Da was used as the lock 
mass. The concentration and the infusion flow rate of leucine-enkephalin were 50 pg/ml and 
10 μl/min, respectively. The tof mass spectrometer was operated in the ‘V’ mode and the 
optimized condition was in consistent with the aforementioned ES+ mode with the exception of 
tof flight tube voltage 7200 V, reflectron voltage 1800 V, pusher voltage 922 V, puller voltage 
750 V and MCP detector voltage 1900 V, respectively. The collision energy was set from 6 V to 
10 V. 
 
Data analysis 
The UPLC–ESI-MS data of different parts of P. notoginseng samples were analyzed to identify 
potential discriminant variables. The peak finding, peak alignment, and peak filtering of ES+ raw 
data were carried out with MarkerLynx applications manager version 4.1 (Waters, Manchester, 
UK) where all the mathematical parameters are set according to our laboratory custom standards. 
The resulting three-dimensional matrix containing arbitrarily assigned peak index, retention time, 
and normalized peak area were further exported to SIMCA-P software 11.0 (Umetrics, Umeå, 
Sweden) for multivariate statistical analysis. PCA scores plot was employed to depict the general 
clustering and groupings on the basis of the metabolic profiles, and the corresponding loadings 
plot was to interpret the variations among the samples. 
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